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Research, University of Oslo, NorwayABSTRACT Previous studies on Serca2 knockout (KO) mice showed that cardiac function is sustained in vivo for several
weeks after knockout, whereas SERCA protein levels decrease and calcium dynamics are significantly impaired. In this study,
we reconcile observed cellular and organ level contractile function using a cardiac multiscale model. We identified and quantified
the changes in cellular function that are both consistent with observations and able to compensate for the decrease in SERCA.
Calcium transients were used as input for multiscale computational simulations to predict whole-organ response. Although this
response matched experimental pressure-volume (PV) measurements in healthy mice, the reduced magnitude calcium tran-
sients observed in KO cells were insufficient to trigger ventricular ejection. To replicate the effects of elevated catecholamine
levels observed in vivo, cells were treated with isoproterenol. Incorporation of the resulting measured b-adrenergically stimu-
lated calcium transients into the model resulted in a close match with experimental PV loops. Changes in myofilament proper-
ties, when considered in isolation, were not able to increase tension development to levels consistent with measurements,
further confirming the necessity of a high b-adrenergic state. Modeling additionally indicated that increased venous return
observed in the KO mice helps maintain a high ejection fraction via the Frank-Starling effect. Our study shows that increased
b-adrenergic stimulation is a potentially highly significant compensatory mechanism by which cardiac function is maintained
in Serca2 KO mice, producing the increases in both systolic and diastolic calcium, consistent with the observed contractile
function observed in experimental PV measurements.INTRODUCTIONWithin the computational biology community, multiscale
modeling has long been proposed as an effective strategy
for integrating experimental data focused on characterizing
function at different scales. Arguably, this approach has
most effectively and significantly been demonstrated in
the development of models of the heart and in particular,
the simulation of electrical activation, mechanical contrac-
tion, and the coupling between these two processes (1,2).
However, what is typically assumed in this process is
that the isolated cellular function, or more specifically
the environment within which the cell interacts, is largely
unchanged between scales. With consistent data sets
(species, temperature, and even genetic background)
becoming available for both cellular and whole organ
cardiac systems, such assumptions can now be tested. In
cases where measurements at one scale are not able to
be fully explained at another, differences between the
in vivo and in vitro function have the potential to be sepa-
rated, providing more insight into the underlying physi-
ology of the system as a whole. Specifically, in this
study we demonstrate the value of this approach by
applying it to understand a murine model of genetically
induced heart failure and its effects on cardiac excitationSubmitted October 15, 2012, and accepted for publication January 22,
2013.
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scales.
In our genetically modified mice, the Serca2 gene is
knocked out, leading to a major disruption in the function
of the sarcoplasmic reticulum (SR). The SR is an intracel-
lular compartment that functions as a calcium store, and-
the SR function accounts for up to 90% of calcium
cycling in mice (3). Uptake of calcium into this store is regu-
lated by the sarco(endo)plasmic reticulum Ca2þ-ATPase 2
(SERCA2) ion pump, and decreased SERCA2 function
has been associated with both systolic and diastolic heart
failure across species (4). Because a full knockout of the
Serca2 gene is lethal in utero (5), we use a cardiomyo-
cyte-specific gene knockout in adult mice (6), which results
in mice that are viable for 7–10 weeks after gene knockout
(4). However, even though protein content is reduced to
<5% by 4 weeks after knockout, observed cardiac function
is maintained at near normal levels. Only after 7 weeks do
the mice develop more severe cardiac dysfunction (7).
This sustained function of the heart, despite a large reduc-
tion in SERCA2 function, suggests the existence of signifi-
cant compensatory mechanisms that may be important in
understanding SERCA-related heart failure in humans.
Previous experiments on isolated myocytes, combined
with mathematical modeling, has shown that calcium tran-
sients are compensated for by upregulation of transmem-
brane calcium dynamics, most importantly the L-typehttp://dx.doi.org/10.1016/j.bpj.2013.01.042
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Furthermore, there are adaptive changes in the cell geom-
etry, including T-tubule remodeling and a decrease in SR
volume (9). However, despite these compensatory mecha-
nisms, calcium transients in cells from knockout (KO)
mice remain very small, an observation that is fundamen-
tally inconsistent with the whole-organ response.
We hypothesize that this discrepancy appears because
previous observations in isolated myocytes were performed
mainly in the absence of other factors present in vivo, and
with many experiments performed at stimulation frequen-
cies much lower than the physiological heart rate. The
importance of this issue is highlighted by the significant
differences between observed cellular function compared
to in vivo function due to complex feedback mechanisms,
in particular the influence that length- and velocity-depen-
dent feedback has on tension generation throughout the
heart cycle (10). Investigating these feedback mechanisms
is difficult in isolated cells. However, as outlined previously,
computational modeling can provide a biophysically consis-
tent framework with the means to incorporate the effects of
regulatory pathways on calcium and contractile dynamics.
Applying this approach, we show that despite the several
compensatory mechanisms previously identified in regu-
lating calcium dynamics, the small calcium transients
previously measured in single cells are still not compatible
with the observed whole-organ function. Furthermore, we
demonstrate that the addition of isoproterenol to induce
a high b-adrenergic state in knockout cells causes significant
changes in measured calcium transients. These changes can
fully explain the observed alterations in cardiac function
after knockout, in turn providing new, to our knowledge,
insight into the progression of heart failure with decreased
SERCA2 function. The changes in calcium are consistent
with the known effects of b-adrenergic stimulation, which
include increased SERCA and L-type calcium influx,
changes in calcium sensitivity, and myofilament properties
(11,12). This result is also consistent with previous observa-
tions of increased norepinephrine levels in KO mice (7),
which have previously not been taken into account in exper-
iments on isolated myocytes at physiological pacing rates,
and are difficult to quantify in vivo. Through the application
of data-driven computational modeling, we quantify the
whole-organ response to decreased calcium transients in
KO mice and show that the disparities observed require
the significant changes in calcium transients induced by
b-adrenergic stimulation to reconcile cellular and whole-
organ function.MATERIALS AND METHODS
Experimental methods
We use genetically modified Serca2flox/flox Tg(a-MHC MerCreMer) mice,
in which injection of tamoxifen induces disruption of the Serca2 gene in
cardiomyocytes (7). Measurements were performed 4 and 7 weeks afterBiophysical Journal 104(6) 1349–1356injection, in separate groups of mice, referred to as KO4 and KO7 mice.
Control flox/flox mice at the same age as KO7 mice are denoted by FF.
Pressure-volume (PV) loops were measured in FF, KO4, and KO7 mice
as previously described (10). Calcium transients were measured during
6 Hz stimulation using whole-cell fluorescence with and without
200 nmol/L isoproterenol. For more details on the experimental methods,
see the Supporting Material.Computational modeling methods
Simulations on a left ventricular (LV) geometry were performed using
the mechanics framework previously described (10,13). Experimental
measurements for calcium transients were used to drive the computational
model, rather than an electrophysiological model as used previously. We
performed simulations for calcium transients measured in FF, KO4, and
KO7 mice, both with and without isoproterenol (referred to as þISO and
control). In all cases the calcium sensitivity ½Ca2þrefT50, which determines
the half-maximal activation of calcium binding to TnC, was set to match
end-diastolic volume at end-diastolic pressure, as this affinity is known to
change in vivo depending on regulatory factors. Other contractile parame-
ters were unchanged from previous work, where they were determined to
match healthy mouse tension generation at physiological temperature and
frequency. Hemodynamic parameters for transitions from isovolumetric
contraction (IVC) to ejection, and from isovolumetric relaxation (IVR) to
diastole were taken from representative traces of experimental PV data,
see Table 2 for summary. Due to rapid murine electrical activation, we
modeled electrical activation as instantaneous, causing tension develop-
ment to initiate homogeneously. As heart failure was observed in these
animals without hypertrophy (7), the LV geometry and constitutive proper-
ties used were identical to previous work (10).
Since comparing PV loops can obscure temporal differences in results,
we also investigated whole-organ tension development. Performing such
comparisons requires an estimate of active tension from experimental
results. This mean active tension was estimated by prescribing pressure
and numerically determining the level of active tension required in the
mechanics solution to match experimentally measured volume using the
PV measurements described in the previous section.
To support the previous simulations, where only the calcium sensi-
tivity ½Ca2þrefT50 was changed, we also investigated alternate compensatory
mechanisms in the contraction model parameters. In each of these simula-
tions, the calcium sensitivity ½Ca2þrefT50 was fitted individually as in previous
simulations, after variation of fundamental contractile parameters: the Hill
coefficient for cooperative cross-bridge action nxb, the reference maximal
isometric tension nxb, and the magnitude of length-dependent activation
effects b1. We also investigated changing the rate constants, the unbinding
rate of calcium from TnC, kTRPN, and the scaling factor for rate of cross-
bridge binding kxb. These simulations were only performed for the KO4
and KO7 mouse models, as the FF model already shows realistic contrac-
tion under control conditions.
For more details on the mathematical models and active tension estima-
tion, see the Supporting Material.RESULTS
Representative calcium transients are shown in Fig. 1, along
with details of diastolic and peak calcium measurements in
Table 1. In untreated cells, we have observed diastolic
calcium is unaltered after knockout across a range of
frequencies (~200 nmol/L at 6 Hz (4)), and these values
were used to calibrate measurements in this study. In FF
mice, treatment with isoproterenol significantly reduced
diastolic calcium levels and increased peak calcium. In
KO mice, peak levels of intracellular calcium were also
FIGURE 1 Calcium transients without (control) and with (þISO) isoproterenol. Representative calcium transients used in simulations. Accompanying
Table 1 shows details of peak and minimum calcium concentrations. In control mice, diastolic calcium was maintained, whereas peak calcium decreases
significantly after knockout. With isoproterenol, diastolic calcium decreases in FF due to upregulated SERCA, but increases in KO due to a lack of SERCA
and increased calcium influx. Peak calcium increases with isoproterenol to reach levels approximately equal to FF control levels.
TABLE 2 Simulated parameters taken from experimental PV
loops
Metric FF KO4 KO7
EDV adj. (ml) 58.9 54.6 55.0
EDP (kPa) 1.02 1.66 3.02
SEP (kPa) 10.5 9.8 11.1
Min. P (kPa) 0.08 1.28 2.35
Heart Failure Progression in KO Mice 1351augmented by isoproterenol. However, due to compromised
SERCA function, diastolic calcium levels increased (all
significant, unpaired t-tests p<0:05). Rather than maintain-
ing diastolic calcium as seen in control mice before and
after knockout, the calcium transients for KO4þISO and
KO7þISO have peak calcium levels not significantly
different from each other and that of the FF control
(ANOVA p ¼ 0:945). (Table 2).
These six representative calcium transients were used as
input for simulations of LV function. The resulting PV loops
from simulations were compared with experimental data in
Fig. 2. These results show that control calcium transients in
KO mice are incompatible with observed whole heart func-
tion, as the predicted maximum pressures of 7–8 kPa are
not sufficient to initiate ejection. However, calcium tran-
sients recorded in KO cells stimulated with isoproterenol
reproduced experimental PV loops. For FF mice, PV loops
obtained with control calcium transients matched experi-
mental data, whereas transients recorded during isoproter-
enol resulted in an ejection fraction significantly larger
than seen in experimental data.
Fig. 3 shows cellular tension estimated from experimental
PV data compared to active tension from these six simulated
cases. These estimated tension traces show more clearly the
unphysiological results produced by using the þISO
calcium transient in the FF mouse model. After the usual
fast decrease in tension development at the beginning of
ejection due to the velocity-dependent effects of fast short-TABLE 1 Calcium dynamics without (control) and with
(DISO) isoproterenol
Control min Ca
FF KO4 KO7
Calibrated to 200 nmol/L
Control peak Ca (nmol/L) 4425 25 2505 5 2365 5
þISO min Ca (nmol/L) 1525 11 251523 4305 17
þISO peak Ca (nmol/L) 9905 135 4595 84 4305 29
Details of peak and minimum calcium concentrations as mean5 SE in FF
(n ¼ 7), KO4 (n ¼ 12), and KO7 (n ¼ 10) mice.ening, there is a second phase of tension development,
leading to a peak tension twice as high as estimated
from experimental data. In comparison, the control
calcium transients in KO mice were too small to result in
a simulated model contraction consistent with the observed
measurements.
Fig. 4 shows the predicted deformation for FF, KO4, and
KO7 mice from the relevant simulations. These results show
the striking similarities in ejection, especially between FF
and KO4, regardless of differences in IVC and IVR. In
KO7, ejection is markedly decreased even following
a more rapid IVC phase due to higher residual tension.
To investigate the necessity of b-adrenergic stimulation
in light of the assumptions inherent in a contraction model,
we also performed an analysis of alternate means to
generate more tension in the model that was consistent
with the observed experimental data, using changes in
contraction model parameters. Table 3 and Fig. 5 show
the results for alternate contraction models in the KO4
and KO7 control cases. In the KO4 model, doubling theControl ½Ca2þrefT50 (mmol/L) 0.578 0.469 0.423
þISO ½Ca2þrefT50 (mmol/L) 0.427 0.588 0.661
EDV adj. is end-diastolic volume adjusted by 15ml to account for muscles
included in simulation cavity volume but not in PV volume (as previously
determined by comparison with MRI data (10)). EDP is end-diastolic
pressure. SEP is the pressure at start of ejection, used to determine end
of IVC. Min. P is the minimal pressure, used to determine end of IVR.
The parameter ½Ca2þrefT50 is the half-activation of calcium binding to TnC
at resting sarcomere length, and was fitted such that EDV matches within
0.1ml when prescribing EDP. Calcium sensitivity ½Ca2þrefT50 was chosen
such that EDV matches experimental data when EDP is prescribed, sepa-
rately in control and þISO cases.
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FIGURE 2 PV loops from simulations based on calcium transients without (control) and with (þISO) isoproterenol, compared to experimental PV data.
Panels show results in FF, KO4, and KO7 mice from left to right. For simulations that do not reach ejection, maximal pressure is indicated by an x.
1352 Land et al.rate constants kTRPN; kxb, simulating increased reaction rates
for troponin C and cross-bridge binding, respectively, has
little effect. Increasing the cooperativity of cross-bridge
binding from nxb ¼ 5 to nxb ¼ 7 has the greatest effect,
but simulation results are still far from experimental traces.
Furthermore, this change leads to an F-pCa Hill curve fit
with a Hill coefficient of 9.1, and a biphasic fit with coeffi-
cients 10.8 and 5.1 for the lower and upper half, respec-
tively, which exceeds experimentally measured Hill
coefficients (14). Increasing the reference tension to
240 kPa, results in only a small increase in the maximum
pressure, as it requires a lower calcium sensitivity to
match the end-diastolic state. Finally, maximum pressure
increased by decreasing the magnitude of length-dependent
activation (LDA) factor b1. This possibly counterintuitive
mechanism is related to the fact that calcium sensitivity
has to be decreased significantly at higher LDA to match
residual tension. Lowering LDA thus allows for higher
sensitivity to calcium, and slightly higher developed
tension. This lower length dependence also results in
a cellular response significantly lower than the length
dependence seen in experiments. In KO7 mice the balance
between required changes in calcium sensitivity andFIGURE 3 Active tension from simulations based on calcium transients in th
PV data. Panels show results in FF, KO4, and KO7 mice from left to right, all ali
KO4 and KO7 are 6Hz, and experimental data for FF is at 7.5Hz.
Biophysical Journal 104(6) 1349–1356maximum pressure changes in some cases. However, the
overall conclusions remain the same: only changes in refer-
ence tension and cooperativity inconsistent with observed
experimental values have the potential to significantly
increase maximum pressure. In the KO7 case there is no
ejection in any simulation, which further shows that the
control calcium transients are incompatible with whole-
organ function observed. This shows the necessity of
b-adrenergic stimulation in maintaining cardiac function
in KO mice, as even large compensatory changes in myofil-
ament properties did not result in viable cardiac output.DISCUSSION
Through a combination of novel, to our knowledge, experi-
mental data and data-driven multiscale mathematical
modeling at both the single cell and whole-organ levels,
we have been able to explain the compensation for heart
failure in Serca2 KO mice. Our results show that
b-adrenergic stimulation is a potentially highly significant
factor in explaining the observed changes from FF to KO
mice and the relatively slow development of heart failure
after a major disruption in normal cellular function.e absence and presence of ISO, compared to active tension estimated from
gned by end-diastole. Heart rates for simulations, and experimental data for
FIGURE 4 Deformation from simulations based on FF control, KO4þISO, and KO7þISO. Surfaces are colored according to active tension, and fiber
direction arrows are colored according to fiber strain, as shown in the legend. Top row shows FF at end-diastole, mid IVC, beginning, mid, end ejection,
and beginning of diastole. Middle row shows KO4 and bottom row KO7.
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calcium transients shows realistic pressure and tension
development and ejection consistent with experimental
measurements and previous modeling (10). For the FF
animals, added isoproterenol produced unrealistic tension
development due to velocity-dependent effects during fast
shortening, as well as an ejection fraction significantly
greater than values measured experimentally. Furthermore,
higher calcium sensitivity is needed to explain the diastolicTABLE 3 Whole-organ response to changes in the
contraction model, using control calcium for KO4 and
KO7 mice
Parameter
KO4 KO7
½Ca2þrefT50 Max. pressure ½Ca2þ
ref
T50 Max. pressure
Original 0.469 7.5kPa 0.423 8.0kPa
kTRPN ¼ 0:2=ms 0.470 7.5kPa 0.429 7.7kPa
kxb ¼ 0:2=ms 0.469 7.5kPa 0.426 7.9kPa
nxb ¼ 7 0.420 10.0kPa 0.399 8.8kPa
Tref ¼ 240kPa 0.511 8.6kPa 0.469 8.6kPa
b1 ¼ 0:75 0.446 7.7kPa 0.412 7.4kPa
Shown are the necessary changes in ½Ca2þrefT50 to match the end-diastolic
state, and resulting maximal pressure developed. The relevant original
contraction model parameters are: Hill coefficient for cooperative cross-
bridge action, nxb ¼ 5. Unbinding rate of calcium from TnC,
kTRPN ¼ 0:1. Scaling factor for rate of cross-bridge binding,
kxb ¼ 0:1=ms. Reference maximal isometric tension, Tref ¼ 120 kPa.
Magnitude of length-dependent activation effects, b1 ¼ 1:5.tension observed experimentally when diastolic calcium is
lowered by upregulated SERCA. In contrast, b-adrenergic
stimulation generally causes lower calcium sensitivity due
to the effects of protein kinase A on Troponin I and
Troponin C (12).
In KO4 and KO7 mice, control calcium transients are too
small to result in the observed ejection fraction, as they
cannot sustain the systolic tension observed even when dia-
stolic tension is significantly elevated. Furthermore, the
observed reduction in the magnitude of the calcium tran-
sients of >70% is too large to be explained by minor
changes in contractile function. With b-adrenergic stimu-
lated calcium transients, simulations matched observed PV
data, showing realistic ejection and tension development.
Matching these experimental results also required a decrease
in calcium sensitivity between control and þISO contrac-
tion in the model to be consistent with diastolic tension,
which is due to higher diastolic calcium in the absence of
sufficient upregulation of SERCA. The small decrease in
calcium sensitivity from FF control to KOþISO is also
consistent with the effects of b-adrenergic stimulation.
From these results we can now provide a novel, to our
knowledge, interpretation of the progression of heart failure
and compensatory mechanisms that result from knockout
of the Serca2 gene. Several electrophysiological mecha-
nisms compensate for the decrease in SERCA. First, in
the absence of b-adrenergic stimulation, transmembraneBiophysical Journal 104(6) 1349–1356
FIGURE 5 PV loops for parameter variations. PV loops from the original
and nxb ¼ 7 simulations shown in Table 3, compared to experimental PV
loops. For simulations that do not reach ejection, maximal pressure is indi-
cated by an x.
1354 Land et al.calcium dynamics are upregulated to increase the calcium
transient (8). Increased activation of the L-type calcium
channel through b-adrenergic stimulation increases the
calcium transient further, preserving systolic calcium levels
to be equal to those normally observed in healthy mice.
However, in the absence of SERCA this upregulation of
the L-type calcium channel through multiple mechanisms
causes net transmembrane removal of calcium through the
sodium-calcium exchanger and plasma membrane Ca2þ
ATPase pump to be insufficient to maintain diastolic
calcium at healthy levels. When systolic calcium is main-
tained and as the size of the calcium transient decreases
with increasing diastolic calcium, either diastolic tension
must increase or systolic tension must decrease. Consistent
with maintaining cardiac pump function and preventing
systolic heart failure, systolic tension is maintained while
diastolic tension increases significantly. Finally, the result-Biophysical Journal 104(6) 1349–1356ing higher diastolic tension is compensated for through
higher minimum and end-diastolic pressure, which indicates
a higher venous return pressure. Venous return is also known
to be increased by b-adrenergic stimulation, through veno-
dilation and lower splanchnic venous resistance (15). This
further ensures systolic tension can be maintained through
effective length dependence of tension development, by
maintaining end-diastolic volume even in the presence of
this significantly higher diastolic active tension. From our
modeling results and measurements of blood catechol-
amines and calcium transients, we can infer that there is
not a loss of b-adrenergic signaling or responsiveness at
the 7-week point, but a limit on to what extent these effects
can compensate for the failing calcium dynamics. Increas-
ingly severe heart failure develops as the b-adrenergic state
and venous return pressure can no longer be increased,
whereas calcium cycling progressively declines, possibly
further exacerbated by acidosis, Naþ accumulation, and
increased ATP consumption (4,8). In this fragile state,
further increases in diastolic calcium can quickly lead to
decreased end-diastolic volume and reduced contractility,
resulting in death from heart failure. In support of this
view, our preliminary data suggest that in vivo cardiac func-
tion rapidly and markedly declines in KO mice following
the 7-week time point examined in this study.
Interestingly, although the Serca2 KO mice develop heart
failure, it appears that b-adrenergic stimulation is advanta-
geous in this particular situation, and likely necessary for
survival at late stages. Contraction in KO cells is facilitated
by a marked increase in systolic calcium during
b-adrenergic stimulation. Of importance, through actions
in the kidneys, b-adrenergic stimulation promotes fluid
retention and increased venous return, which are tradition-
ally considered deleterious in heart failure. However, in
the KO mice such an increase in preload appears to be
essential in permitting filling of the ventricle despite
increased diastolic active tension. In heart failure,
b-adrenergic stimulation is generally associated with ar-
rhythmogenesis due to overloading of the SR, and thus
spontaneous calcium release (16). However, in the KO
mice, such spontaneous release events are inhibited due to
the low SR content, and thus the proarrhythmic danger of
b-adrenergic stimulation appears to be avoided. Finally,
a detrimental increase in heart rate expected with greater
b-adrenergic tone does not occur in KO mice; in fact, we
have observed a mild decrease in heart rate in these mice
(7). This may be due to the role of SERCA2 in sinoatrial
node cells (17), which are partially affected by the
knockout. Thus, there appears to be several advantages to
increased b-adrenergic stimulation in the Serca2 KO mice,
without the largely negative effects associated with sympa-
thetic stimulation in other types of chronic heart failure. In
humans, the effects of sympathetic stimulation are often
blocked with b-blockers, making them an effective treat-
ment for a range of heart diseases (18). By contrast, KO
Heart Failure Progression in KO Mice 1355animals appear dependent on continuous b-adrenergic stim-
ulation for survival.
A possible limitation of our experimental data is that we
have only considered very high and no b-adrenergic stimu-
lation. Although ejection predicted from KO4 þISO
calcium data is slightly higher compared to PV data, within
the limits of uncertainty of the experimental data, it is
difficult to say whether b-adrenergic stimulation is already
near maximal in KO4 mice. Previously measured blood
catecholamine levels were elevated in KO mice, with
norepinephrine levels of 84.4 5 10.3 in KO7 mice com-
pared to 54.8 5 7.3 mg/g in FF controls, and epinephrine
levels of 5.1 5 1.8 mg/g in KO7 and 2.5 5 5.1 mg/g in
FF mice (7). As blood catecholamines are spillover from
nerve terminals, these measurements cannot be easily con-
verted into equivalent stimulation at the single cell level.
The computational model also has a number of limita-
tions. Most significantly, as there still remains some contro-
versy about the specifics of tension development regulation,
the cardiac contraction model may not capture all changes in
contractile properties. Furthermore, calcium transients were
assumed to be homogeneous throughout tissue in the
computational model. This is likely to be an oversimplifica-
tion, as there is evidence for both apical-basal and transmu-
ral heterogeneities in calcium dynamics in mice (19,20).
Finally, as discussed previously (10), there are a number
of limitations with respect to knowledge of the constitutive
properties of myocardial tissue and boundary effects on
the heart.
The close match of model predictions to data shows the
effectiveness of careful species-specific modeling at physi-
ological temperatures and pacing rates. However, our novel,
to our knowledge, tension estimation method also reveals
some small but striking differences between model predic-
tions and observed tension. Most notably relaxation of
tension during IVR is slower, even considering the small
disparity in heart rate for the FF data. This is likely to be
related to complex length- and velocity-dependent effects,
such as shortening-induced cooperative deactivation of the
filaments (21), which are not included in the contraction
model as their mechanisms remain difficult to quantify.
Effects of b-adrenergic stimulation on the myofilaments
could also play a role (12), although doubling the rate
constant for cross-bridges kxb did not improve relaxation,
suggesting that this is dominated by the calcium transient
decay rate in simulations.
In multiscale modeling, cell models based on isolated
cells are often assumed to perfectly describe whole-organ
behavior. As we have shown, even when using a carefully
species-specific model at a physiological temperature and
pacing frequency, such an assumption may be incorrect. In
this context, our experimental data also reveals some of
the disadvantages of using isolated cell preparations.
Although the cell environment is carefully controlled, iso-
lated cell behavior can be significantly different in compar-ison to in vivo function, as important regulatory factors of
calcium dynamics, such as b-adrenergic stimulation,
changing sarcomere length, and circulatory factors, are
missing. Our results also show an important role for compu-
tational modeling in quantifying the connection between
single cell and whole-organ function. Whereas the
decreased calcium transients seen in the KO mice may
initially seem compatible with the observed decrease in
heart function, modeling results demonstrate that more
significant changes are needed, which can only be induced
by high b-adrenergic stimulation.CONCLUSION
In conclusion, through the integration of novel, to our
knowledge, experimental data collected from both vitro
cellular preparations and live animals, we have been able
to identify a key component of cardiac function that is
important for in vivo function. Specifically, these results
explain the progression of heart failure in Serca2 KO
mice, and highlight the role of increased b-adrenergic stim-
ulation as the major compensatory mechanism.SUPPORTING MATERIAL
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